A study on small bowel scrutiny in diarrhoea associated with the administration of immune checkpoint inhibitors.

A study on small bowel scrutiny in diarrhoea associated with the administration of immune checkpoint inhibitors. - A study on small bowel scrutiny in diarrhoea associated with the administration of immune checkpoint inhibitors.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054068

Enrollment

Registered

2024-04-05

Start date

2023-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhoea associated with administration of immune checkpoint inhibitors

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with suspected diarrhoea associated with ICI administration 2) Patients for whom small bowel capsule endoscopy is (or was) performed for the purpose of ICI scrutiny. 3) Men and women aged 18 years and over at the time of small bowel capsule endoscopy.

Exclusion criteria

Exclusion criteria: (1) Patients who have refused to participate in response to the opt-out.

Design outcomes

Primary

Measure	Time frame
Prevalence of small bowel capsule endoscopy.	—

Countries

Japan

Contacts

Public ContactMisawa Noboru

Yokohama City University Hospital Endoscopy centre

nobomisa@hotmail.co.jp09061961466

Outcome results